HomeINZY • NASDAQ
Inozyme Pharma Inc
Follow
$1.00
0.030%
After Hours:(2.00%)-0.020
$0.98
Closed: Mar 14, 6:06:01 PM GMT-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.17M | 19.13% |
Net income | -27.07M | -25.67% |
Net profit margin | — | — |
Earnings per share | -0.42 | -20.00% |
EBITDA | -26.99M | -19.45% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 113.09M | -40.04% |
Total assets | 123.18M | -38.67% |
Total liabilities | 65.36M | 8.26% |
Total equity | 57.83M | — |
Shares outstanding | 64.24M | — |
Price to book | 1.11 | — |
Return on assets | -50.97% | — |
Return on capital | -57.99% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -27.07M | -25.67% |
Cash from operations | -19.19M | -3.79% |
Cash from investing | 15.44M | 338.64% |
Cash from financing | 258.00K | -97.94% |
Net change in cash | -3.49M | 71.61% |
Free cash flow | -9.30M | 8.30% |
Previous close
$1.00
Day range
$0.98 - $1.03
Year range
$0.98 - $7.79
Market cap
64.24M USD
Avg Volume
594.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
67
